DK162282C - Analogifremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholecalciferoler samt 26,26,26-27,27,27-hexafluor-1alfa,3beta,25-trihydroxycholest-5,7-dien til anvendelse som udgangsmateriale ved fremgangsmaaden - Google Patents

Analogifremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholecalciferoler samt 26,26,26-27,27,27-hexafluor-1alfa,3beta,25-trihydroxycholest-5,7-dien til anvendelse som udgangsmateriale ved fremgangsmaaden

Info

Publication number
DK162282C
DK162282C DK137083A DK137083A DK162282C DK 162282 C DK162282 C DK 162282C DK 137083 A DK137083 A DK 137083A DK 137083 A DK137083 A DK 137083A DK 162282 C DK162282 C DK 162282C
Authority
DK
Denmark
Prior art keywords
1alfa
hexafluor
dihydroxycholecalciferoles
trihyd
3beta
Prior art date
Application number
DK137083A
Other languages
Danish (da)
English (en)
Other versions
DK137083D0 (da
DK162282B (da
DK137083A (da
Inventor
Hector F Deluca
Yoko Tanaka
Nobuo Ikekawa
Yoshiro Kobayashi
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of DK137083D0 publication Critical patent/DK137083D0/da
Publication of DK137083A publication Critical patent/DK137083A/da
Priority to DK554084A priority Critical patent/DK165695C/da
Publication of DK162282B publication Critical patent/DK162282B/da
Application granted granted Critical
Publication of DK162282C publication Critical patent/DK162282C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK137083A 1981-07-27 1983-03-25 Analogifremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholecalciferoler samt 26,26,26-27,27,27-hexafluor-1alfa,3beta,25-trihydroxycholest-5,7-dien til anvendelse som udgangsmateriale ved fremgangsmaaden DK162282C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK554084A DK165695C (da) 1981-07-27 1984-11-22 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28679081 1981-07-27
US06/286,790 US4358406A (en) 1981-07-27 1981-07-27 26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same
US8200909 1982-07-06
PCT/US1982/000909 WO1983000335A1 (fr) 1981-07-27 1982-07-06 26, 26, 26, 27, 27, 27-HEXAFLUORO-1'alpha',25-DIHYDROXYCHOLECALCIFEROL ET SON PROCEDE DE PREPARATION

Publications (4)

Publication Number Publication Date
DK137083D0 DK137083D0 (da) 1983-03-25
DK137083A DK137083A (da) 1983-03-25
DK162282B DK162282B (da) 1991-10-07
DK162282C true DK162282C (da) 1992-03-16

Family

ID=23100174

Family Applications (2)

Application Number Title Priority Date Filing Date
DK137083A DK162282C (da) 1981-07-27 1983-03-25 Analogifremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholecalciferoler samt 26,26,26-27,27,27-hexafluor-1alfa,3beta,25-trihydroxycholest-5,7-dien til anvendelse som udgangsmateriale ved fremgangsmaaden
DK554084A DK165695C (da) 1981-07-27 1984-11-22 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK554084A DK165695C (da) 1981-07-27 1984-11-22 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol

Country Status (14)

Country Link
US (1) US4358406A (fr)
JP (1) JPS58501176A (fr)
AU (2) AU552210B2 (fr)
BE (1) BE893943A (fr)
CH (2) CH656134A5 (fr)
DE (2) DE3248900T1 (fr)
DK (2) DK162282C (fr)
FR (1) FR2510566B1 (fr)
GB (2) GB2102806B (fr)
IE (2) IE54370B1 (fr)
IL (5) IL76090A (fr)
IT (1) IT1157309B (fr)
NL (1) NL8220265A (fr)
WO (1) WO1983000335A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634692A (en) * 1981-08-28 1987-01-06 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxy-24R-fluorocholecalciferol and 1α,25-dihydroxy-24S-fluorocholecalciferol
US4411833A (en) * 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
US4448726A (en) * 1983-05-11 1984-05-15 Wisconsin Alumni Research Foundation Ring A- and triene-modified vitamin D compounds
US4613594A (en) * 1984-11-16 1986-09-23 Hoffmann-La Roche Inc. Fluorinated vitamin D3 compounds
ZA859138B (en) * 1984-12-19 1986-08-27 Hoffmann La Roche Cholecalciferol derivatives
EP0205025A1 (fr) * 1985-05-27 1986-12-17 Sumitomo Pharmaceuticals Company, Limited Dérivés fluorés de vitamine D3 et agents inducteurs de différentiation cellulaire les contenant comme composé actif
US4619920A (en) * 1985-09-16 1986-10-28 Wisconsin Alumni Research Foundation 26,26,26,27,27-pentafluoro-1α-hydroxy-27-methoxyvitamin D3
CA1314872C (fr) 1986-04-25 1993-03-23 Toshio Nishizawa Derives fluores de la vitamine d _et procede pour leur production
JPH0764804B2 (ja) * 1986-04-25 1995-07-12 住友製薬株式会社 活性型ビタミンｄ３のフッ素誘導体
US4853378A (en) * 1986-10-20 1989-08-01 Sumitomo Chemical Company, Limited Fluorine derivatives of vitamin D3 and process for producing the same
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
AU5185790A (en) * 1989-02-16 1990-09-05 University Of Georgia Research Foundation, Inc., The Treatment of tibial dyschondroplasia
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
ATE253921T1 (de) * 1991-05-06 2003-11-15 Procter & Gamble Kombinationen aus calzium und vitamin d
US5753638A (en) * 1992-10-07 1998-05-19 Hoffmann-La Roche Inc. Method of treating hyperproliferative skin disease with Vitamin D3 fluorinated analogs
CA2096105A1 (fr) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Analogues fluores de vitamine d3
CA2147264C (fr) * 1992-10-16 2006-05-16 Tetsuhiro Mikami Derives de la vitamine d et methode de preparation
BR9405735A (pt) * 1993-02-19 1995-12-05 Wisconsin Alumni Res Found Uso de 26,26,26,27,27,27-hexaflúor-1-alfa 25-dihidróxi colecalciferol para o tratamento de distúrbios do metabolismo do cálcio
US5547947A (en) * 1993-03-11 1996-08-20 Hoffmann-La Roche Inc. Methods of treatment
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
IL139241A0 (en) * 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
US6080879A (en) * 1998-05-19 2000-06-27 Tetrionics, Inc. Hexafluoro-vitamin synthesis and crystallization method, solvent and product
JP2011508743A (ja) * 2007-12-28 2011-03-17 ウィスコンシン アラムナイ リサーチ ファンデーション （２０ｓ）−２３，２３−ジフルオロ−２−メチレン−１９−ノル−ビスホモプレグナカルシフェロール−ビタミンｄ類縁体
CA2981549A1 (fr) 2009-01-27 2010-08-05 Berg Llc Vitamines d3 et analogues de celles-ci pour soulagement des effets secondaires associes a une chimiotherapie
SG10201404883YA (en) 2009-08-14 2014-10-30 Berg Llc Vitamin d3 and analogs thereof for treating alopecia
AU2014274099A1 (en) 2013-05-29 2015-12-24 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin D
ES2536256B2 (es) * 2013-11-20 2016-02-01 Universidade De Santiago De Compostela Análogos de vitamina d con interés farmacéutico
CN111960938B (zh) * 2020-08-20 2022-06-17 甘肃皓天医药科技有限责任公司 用于制备氟骨化醇的中间体的制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL45897A (en) * 1974-10-22 1978-12-17 Yeda Res & Dev Process for the preparation of 1 hydroxy-provitamin d3
US4199518A (en) * 1978-03-30 1980-04-22 Diamond Shamrock Corporation 1α,3β-Dihydroxy-steroid-5-enes from 1α,2α-epoxy-steroid-4,6-dien-3-ones
PH16989A (en) * 1978-11-07 1984-05-04 Res Inst Medicine Chem Process for the preparation of 1-hydroxylated vitamin d compounds
US4226788A (en) * 1979-03-28 1980-10-07 Wisconsin Alumni Research Foundation 24,24-Difluoro-1α,25-dihydroxycholecalciferol
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol

Also Published As

Publication number Publication date
JPS58501176A (ja) 1983-07-21
US4358406A (en) 1982-11-09
DE3248900C2 (fr) 1990-12-13
IL76090A (en) 1987-12-31
IL76090A0 (en) 1985-12-31
WO1983000335A1 (fr) 1983-02-03
DE3248900T1 (de) 1983-07-07
GB2118556A (en) 1983-11-02
DK137083D0 (da) 1983-03-25
DK165695C (da) 1993-06-07
IL66351A (en) 1987-12-31
GB8311517D0 (en) 1983-06-02
BE893943A (fr) 1982-11-16
IT1157309B (it) 1987-02-11
DE3250034C2 (fr) 1991-02-28
AU8760582A (en) 1983-03-17
GB2102806A (en) 1983-02-09
NL8220265A (nl) 1983-06-01
IE54369B1 (en) 1989-09-13
DK162282B (da) 1991-10-07
IL76091A0 (en) 1985-12-31
GB2102806B (en) 1985-02-27
IL66351A0 (en) 1982-11-30
JPH0348903B2 (fr) 1991-07-25
AU586267B2 (en) 1989-07-06
FR2510566A1 (fr) 1983-02-04
IL76091A (en) 1987-12-31
DK554084A (da) 1984-11-22
GB2118556B (en) 1985-02-27
CH656134A5 (de) 1986-06-13
CH655307A5 (de) 1986-04-15
AU552210B2 (en) 1986-05-22
AU6056086A (en) 1986-12-18
FR2510566B1 (fr) 1985-06-28
DK165695B (da) 1993-01-04
IE821797L (en) 1983-01-27
IE891226L (en) 1983-01-27
DK554084D0 (da) 1984-11-22
DK137083A (da) 1983-03-25
IT8222574A0 (it) 1982-07-26
IE54370B1 (en) 1989-09-13

Similar Documents

Publication Publication Date Title
DK162282C (da) Analogifremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholecalciferoler samt 26,26,26-27,27,27-hexafluor-1alfa,3beta,25-trihydroxycholest-5,7-dien til anvendelse som udgangsmateriale ved fremgangsmaaden
DK162601C (da) Analogifremgangsmaade til fremstilling af 8-oe4-oe4-(2,1-benzisothiazol-3-yl)-1-piperazinylaabutylaa-8-azaspirooe4.5aadecan-7,9-dion
DK160943C (da) Analogifremgangsmaade til fremstilling af acyloxyalkyl-6-(alfa, alfa-disubstituerede acetamido)penicillanater samt et udgangsmateriale til fremstilling heraf
NO162121C (no) Fremgangsmaate ved fremstilling av titan, samt apparat forutfoerelse av fremgangsmaaten.
DK268385A (da) Lysfoelsomme mikrokapsler og lysfoelsomt materiale, indeholdende disse, samt anvendelse deraf til dannelse af flerfarvede billeder
NO158630C (no) Poroest, tverrbundet polymert blokkmateriale, samt fremgangsmaate for fremstilling av et slikt.
NO871830D0 (no) Komposittelektroder, framgangsmaate for framstilling av disse samt apparat der elektrodene benyttes.
DK94787D0 (da) Apparat samt fremgangsmaade til haandtering af stoffer
DK528982A (da) Fremgangsmaade til fremstilling af 13,14-didehydro-prostaglandiner
NO832610L (no) Derivater av morfolinyl-daunorubicin og morfolinyl-doxorubicin og analoge derav samt fremgangsmaate for fremstilling av disse
DK156001C (da) Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner
DK145787D0 (da) Fremgangsmaade til maling af fortrinsvis hoejviskose vaeskers flydeegenskaber samt apparat til udfoerelse af fremgangsmaaden
DK158664C (da) Analogifremgangsmaade til fremstilling af benzoxazinoner og benzoxazolinoner samt forbindelser til anvendelse ved fremgangsmaaden.
DK631986A (da) Fremgangsmaade samt apparat til kalcinering.
DK446082A (da) Fremgangsmaade til fremstilling af chlordioxid samt apparat til anvendelse derved
NO821270L (no) Fremgangsmaate ved fremstilling av metallklorider, samt anordning for utfoerelse av fremgangsmaaten
DK520279A (da) Pyrrolo-eller pyrido(2,1-c)(1,4)thiaziner eller-thiazepiner samt fremgangsmaade til anvendelse af saadanne forbindelser som mellemprodukter
DK215681A (da) Fremgangsmaade samt apparat til frmstilling af alkansulfonylchlorider
DK327882A (da) Fremgangsmaade til gennemfoerelse af plasmaferese ved frem- og tilbagegaaende pulserende filtrering samt apparat til brug vedfremgangsmaaden
DK165245C (da) 5-phenyl-5h-indenooe1,2-daapyrimidiner, fremgangsmaade til fremstilling af disse samt anvendelse af forbindelserne
DK523781A (da) Fremgangsmaade til fremstilling af benzylpyrimidiner samt mellemprodukt for disse
DK7483A (da) Fremgangsmaade til fremstilling af 6-aminoalkylpencillansyre-1,1-dioxider samt derivater deraf
EP0104258A4 (fr) Batonnet pour chromatographie et procede de developpement d'un echantillon utilisant ce batonnet.
DK148883C (da) Analogifremgangsmaade til fremstilling af ergolinderivater samt ergolinderivater til anvendelse som udgangsmateriale hertil
NO823431L (no) Fremgangsmaate ved vakuumpakking, samt apparat for anvendelse ved fremgangsmaaten

Legal Events

Date Code Title Description
PBP Patent lapsed